Prophylactic for Endemic Diarrheal Diseases

Abstract

Demonstrate bacterial diarrheal prophylactic candidate safety, effectiveness, and pharmacokinetics through clinical trials in humans. Transition the prophylactic candidate to product developer in support of future FDA licensure. Research is conducted in compliance with FDA regulations for medical products for human use. Work is managed by the United States Army Medical Research and Development Command (USAMRDC) in coordination with the Naval Medical Research Center (NMRC). The Army is responsible for programming and funding all Department of Defense (DoD) naturally occurring infectious disease research requirements, thereby precluding duplication of effort within the Military Departments. The cited work is consistent with the Under Secretary of Defense (Research and Engineering) science and technology focus areas and the Army Modernization Strategy. Work in this Project is performed by the USAMRDC, Fort Detrick, MD. Efforts in this Project support the Soldier portfolio and the principal area of Military Relevant Infectious Diseases.

Open PDF

Document Details

Document Type
Project
Publication Date
Oct 01, 2022
Source ID
CJ3_0603002A_3_2040_PB_2022

Tags

Fields of Study

  • Medicine

Readers

  • Infectious Disease/Epidemiology
  • Military Science and Technology Research and Modernization.

Related Documents